Baader Bank Aktiengesellschaft Edwards Lifesciences Corp Put Options Transaction History

Baader Bank Aktiengesellschaft

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Jul 17, 2024	BUY	$84.3 - $94.31 $2.93 Million - $3.28 Million	34,800 Added 57.81%	95,000 $8.78 Million
Q1 2024 May 03, 2024	BUY	$72.54 - $95.56 $4.37 Million - $5.75 Million	60,200 New	60,200 $5.75 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $111,390 - $126,765	-1,500 Reduced 1.27%	116,500 $9.64 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $8.06 Million - $10.3 Million	118,000 New	118,000 $8.8 Million
Q3 2022 May 04, 2023	SELL	$82.37 - $107.29 $2.99 Million - $3.89 Million	-36,300 Reduced 30.76%	81,700 $6.75 Million
Q2 2022 Aug 11, 2022	BUY	$86.5 - $128.27 $7.07 Million - $10.5 Million	81,700 New	81,700 $3.38 Million

1,350

457M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Baader Bank Aktiengesellschaft, based on Form 13F filings with the SEC.

Stay updated on Baader Bank Aktiengesellschaft with notifications on news.